ClinicalTrials.govpublic full text
Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive
head and neck neoplasms, neoplasm metastasis, recurrent disease, progressive disease, metastatic head and neck cancer, pi3k inhibitor, recurrent head and meck cancer, progressive head and neck cancer, bkm120, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800378
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.